Immunic, Inc. (IMUX) stock
IMUXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.33+0.10 (+1.38%)
Close on Nov 17, 2026Market cap $100.01MP/E –Yield 0.00%
Immunic cash
Cash and short-term investments held at the end of each period.
Immunic's cash was $155.10M at Jun 30, 2026. For fiscal 2025 it was $15.48M, down 56.6% from the year before. Over ten years it grew -15.5% a year on average. The highest annual figure on record is $127.45M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.48M | -56.6% |
| FY2024 | Dec 31, 2024 | $35.67M | -23.6% |
| FY2023 | Dec 31, 2023 | $46.67M | -56.3% |
| FY2022 | Dec 31, 2022 | $106.75M | +22.9% |
| FY2021 | Dec 31, 2021 | $86.86M | -31.8% |
| FY2020 | Dec 31, 2020 | $127.45M | +334.0% |
| FY2019 | Dec 31, 2019 | $29.37M | +124.7% |
| FY2018 | Dec 31, 2018 | $13.07M | +190.2% |
| FY2017 | Dec 31, 2017 | $4.50M | -92.5% |
| FY2016 | Dec 31, 2016 | $59.99M | -28.1% |
| FY2015 | Dec 31, 2015 | $83.42M | -18.4% |
| FY2014 | Dec 31, 2014 | $102.24M | +167.7% |
| FY2013 | Dec 31, 2013 | $38.19M | +752.9% |
| FY2012 | Dec 31, 2012 | $4.48M | +457.5% |
| FY2011 | Dec 31, 2011 | $803.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $155.10M | +180.4% |
| Q1 FY2026 | Mar 31, 2026 | $186.63M | +1204.7% |
| Q4 FY2025 | Dec 31, 2025 | $15.48M | -56.6% |
| Q3 FY2025 | Sep 30, 2025 | $35.13M | -40.5% |
| Q2 FY2025 | Jun 30, 2025 | $55.31M | -30.6% |
| Q1 FY2025 | Mar 31, 2025 | $14.30M | -85.3% |
| Q4 FY2024 | Dec 31, 2024 | $35.67M | -23.6% |
| Q3 FY2024 | Sep 30, 2024 | $59.07M | -1.0% |
| Q2 FY2024 | Jun 30, 2024 | $79.70M | +3.1% |
| Q1 FY2024 | Mar 31, 2024 | $97.31M | +4.9% |
| Q4 FY2023 | Dec 31, 2023 | $46.67M | -56.3% |
| Q3 FY2023 | Sep 30, 2023 | $59.69M | -18.0% |
| Q2 FY2023 | Jun 30, 2023 | $77.29M | -12.2% |
| Q1 FY2023 | Mar 31, 2023 | $92.76M | -3.1% |
| Q4 FY2022 | Dec 31, 2022 | $106.75M | +22.9% |
| Q3 FY2022 | Sep 30, 2022 | $72.77M | -34.1% |
| Q2 FY2022 | Jun 30, 2022 | $88.08M | +1.0% |
| Q1 FY2022 | Mar 31, 2022 | $95.71M | -16.7% |
| Q4 FY2021 | Dec 31, 2021 | $86.86M | -31.8% |
| Q3 FY2021 | Sep 30, 2021 | $110.44M | -17.1% |
| Q2 FY2021 | Jun 30, 2021 | $87.18M | +79.3% |
| Q1 FY2021 | Mar 31, 2021 | $114.84M | +518.1% |
| Q4 FY2020 | Dec 31, 2020 | $127.45M | +334.0% |
| Q3 FY2020 | Sep 30, 2020 | $133.18M | +337.2% |
| Q2 FY2020 | Jun 30, 2020 | $48.61M | +34.6% |
| Q1 FY2020 | Mar 31, 2020 | $18.58M | +144.7% |
| Q4 FY2019 | Dec 31, 2019 | $29.37M | +124.7% |
| Q3 FY2019 | Sep 30, 2019 | $30.46M | +204.0% |
| Q2 FY2019 | Jun 30, 2019 | $36.12M | +197.8% |
| Q1 FY2019 | Mar 31, 2019 | $7.59M | -82.6% |
| Q4 FY2018 | Dec 31, 2018 | $13.07M | +190.2% |
| Q3 FY2018 | Sep 30, 2018 | $10.02M | -84.9% |
| Q2 FY2018 | Jun 30, 2018 | $12.13M | -84.1% |
| Q1 FY2018 | Mar 31, 2018 | $43.65M | -49.6% |
| Q4 FY2017 | Dec 31, 2017 | $4.50M | -92.5% |
| Q3 FY2017 | Sep 30, 2017 | $66.39M | -2.5% |
| Q2 FY2017 | Jun 30, 2017 | $76.15M | – |
| Q1 FY2017 | Mar 31, 2017 | $86.64M | – |
| Q4 FY2016 | Dec 31, 2016 | $59.99M | – |
| Q3 FY2016 | Sep 30, 2016 | $68.09M | – |
See a number that looks wrong?